Publications by authors named "A Redwood"

Article Synopsis
  • Spillover from wild animals threatens human health, with few successful global solutions, one of which is the use of oral vaccines for rabies in certain regions.
  • There's interest in developing 'transmissible' vaccines that can spread immunity among wildlife, but they raise environmental concerns due to potential release of genetically modified viruses.
  • The study proposes a method to control the stability of these vaccines' genetic material, allowing for better management and fine-tuning of their lifespan in wild animal populations through specific genetic adjustments.
View Article and Find Full Text PDF

Background: Anti-tumor CD8 T cells are important for immunity but can become 'exhausted' and hence ineffective. Tumor-infiltrating exhausted CD8 T cells include less differentiated stem-like exhausted T (Tex) cells and terminally exhausted T (Tex) cells. Both subsets have been proposed as prognostic biomarkers in cancer patients.

View Article and Find Full Text PDF
Article Synopsis
  • Cancer immunogenomics combines the study of genes and the immune system to learn more about cancer.
  • New technologies allow scientists to look at cancer cells closely and find important changes that could help treat patients.
  • The review talks about different computer methods used to analyze cancer data and how to choose the right tool to help doctors improve cancer treatments for patients.
View Article and Find Full Text PDF
Article Synopsis
  • Researchers focused on cytomegaloviruses (CMVs) in Natal multimammate mice, a species found in sub-Saharan Africa and linked to zoonotic diseases like Lassa virus (LASV).
  • They isolated infectious CMVs from these mice and sequenced multiple genomes, identifying three distinct CMV types (MnatCMV1, MnatCMV2, and MnatCMV3) and discovering cases of coinfection.
  • The findings help understand CMV diversity and are aimed at developing a vaccine based on MnatCMVs to combat LASV in its animal reservoir.
View Article and Find Full Text PDF
Article Synopsis
  • Patient-derived xenograft (PDX) models of breast cancer offer a powerful method for drug testing and discovering biomarkers, especially in triple-negative breast cancer (TNBC).
  • The research involved creating PDX models from breast cancer patients before and after neoadjuvant chemotherapy, resulting in 62 successful models from a total of 269 samples, with better success rates from treatment-resistant tumors.
  • A predictive model for PDX engraftment was established, focusing on key patient tumor characteristics, and these PDX models are now a valuable resource for advancing treatment strategies in TNBC.
View Article and Find Full Text PDF